[HTML][HTML] Enabling accelerated vaccine roll-out for public health emergencies of international concern (PHEICs): novel oral polio vaccine type 2 (nOPV2) experience

GR Macklin, C Peak, M Eisenhawer, F Kurji, O Mach… - Vaccine, 2023 - Elsevier
To address the evolving risk of circulating vaccine-derived poliovirus type 2 (cVDPV2),
Global Polio Eradication Initiative (GPEI) partners are working closely with countries to …

[PDF][PDF] Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience

G Macklin, C Peak, M Eisenhawer, F Kurji, O Mach… - 2022 - researchgate.net
abstract To address the evolving risk of circulating vaccine-derived poliovirus type 2
(cVDPV2), Global Polio Eradication Initiative (GPEI) partners are working closely with …

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.

GR Macklin, C Peak, M Eisenhawer, F Kurji, O Mach… - Vaccine, 2022 - europepmc.org
To address the evolving risk of circulating vaccine-derived poliovirus type 2 (cVDPV2),
Global Polio Eradication Initiative (GPEI) partners are working closely with countries to …

[PDF][PDF] Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience

G Macklin, C Peak, M Eisenhawer… - … against type-2 …, 2022 - researchonline.lshtm.ac.uk
To address the evolving risk of circulating vaccine-derived poliovirus type 2 (cVDPV2),
Global Polio Eradication Initiative partners are working closely with countries to deploy an …

Enabling accelerated vaccine roll-out for public health emergencies of international concern (PHEICs): novel oral polio vaccine type 2 (nOPV2) experience.

GR Macklin, C Peak, M Eisenhawer, F Kurji, O Mach… - 2023 - cabidigitallibrary.org
To address the evolving risk of circulating vaccine-derived poliovirus type 2 (cVDPV2),
Global Polio Eradication Initiative (GPEI) partners are working closely with countries to …

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience

GR Macklin, C Peak, M Eisenhawer, F Kurji… - …, 2023 - pubmed.ncbi.nlm.nih.gov
To address the evolving risk of circulating vaccine-derived poliovirus type 2 (cVDPV2),
Global Polio Eradication Initiative (GPEI) partners are working closely with countries to …

[HTML][HTML] Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience

GR Macklin, C Peak, M Eisenhawer, F Kurji, O Mach… - Vaccine, 2023 - ncbi.nlm.nih.gov
To address the evolving risk of circulating vaccine-derived poliovirus type 2 (cVDPV2),
Global Polio Eradication Initiative (GPEI) partners are working closely with countries to …

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience☆

G Macklin, C Peak, M Eisenhawer, F Kurji, O Mach… - Vaccine, 2023 - europepmc.org
To address the evolving risk of circulating vaccine-derived poliovirus type 2 (cVDPV2),
Global Polio Eradication Initiative (GPEI) partners are working closely with countries to …

[引用][C] Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience

G Macklin, C Peak, M Eisenhawer, F Kurji, O Mach… - 2022